Observational Study Of Donepezil In Routine Clinical Practice

Pfizer

Status: Terminated

Conditions: Alzheimer's Disease

Treatments: Other: donepezil

Study type: Observational

Funder types: Industry

Identifiers

NCT00843115

ECO STUDY

NRA2500065

Details and patient eligibility

About

To characterize the comorbidities and medications of patients treated with donepezil in a routine clinical practice and to verify the therapeutic response of these patients.

Full description

This trial was terminated prematurely on December 31, 2007 due to difficulties in enrolling patients in the study. There were no safety or efficacy concerns regarding the study in the decision to terminate the trial.

Enrollment: 370 patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• DSM-IV criteria for the clinical diagnosis of mild to moderate Alzheimer's Disease with or without other etiologies of dementia
• Mini Mental Status Examination score of 10-26

Exclusion criteria

• Contraindication as stated in the Canadian label for donepezil
• Subjects treated with medication for dementia within 30 days prior to baseline

Trial design

370 participants in 1 patient group

Observational

Description:

This study was non-interventional and simply followed for 3 months patients initiating a treatment with donepezil

Treatment:

Other: donepezil